Iron Sucrose Complex

A niche API used in its finished form (injectable) is used as a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. Available for all global markets along with DMF support.

A niche API used in its finished form (injectable) is used as a vasodilator with or without other medications to treat high blood pressure. Available for all global markets along with DMF support.

A niche API used in its finished form (tablet) indicated as an adjunct to diet and exercise to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia (Fredrickson Type IIa) as monotherapy or in combination with a hydroxymethyl-glutaryl-coenzyme A (HMG CoA) redu...

A niche API used in its finished form (tablet) indicated as an adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet. Available for all global markets except the US and Europe al...

A niche API used in its finished form (injectable) indicated for the treatment of iron deficiency anemia. It is used in patients with kidney disease who are receiving dialysis. Available for all global markets except the US along with DMF support.

A niche API used in its finished form (injectable and tablet) indicated for the treatment of vitamin K1 deficiency, and to treat certain bleeding or blood-clotting problems caused by other medicines or medical conditions. Oral grade available for all global markets along with DMF support and injectable...

A niche API used in its finished form (injectable) indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia.  Available for all global markets along with DMF support.

A niche oncology API manufactured by us used ultimately in its finished form (injectable) for the treatment of indolent B-cell non-Hodgkin lymphoma. Available for all global markets along with DMF support

A niche oncology API used for the treatment of malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma. multiple myeloma.. Available for all global markets ex...

A niche oncology API used for the treatment of multiple myeloma and ovarian cancer. Melphalan HCl Injection, at high intravenous dosage, is indicated, with or without haematopoietic stem cell transplantation, for the treatment of multiple myeloma and childhood neuroblastoma. Available for all global mar...

A niche API used in its finished form (tablet) for the treatment of hyperphosphatemia in patients with chronic kidney disease. Available for all global markets along with DMF support.

A niche API used in its finished form (tablet) for the treatment of hyperphosphatemia in patients with chronic kidney disease. Available for all global markets along with DMF support.